RedHill Biopharma Net Debt Growth & History (RDHL)

RedHill Biopharma's net debt was −$2.9M for fiscal 2025.

View full RedHill Biopharma company overview

RedHill Biopharma annual net debt history

RedHill Biopharma annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$2.9M$1.4M
20242024-12-31−$4.3M$135,000
20232023-12-31−$4.4M−$107.1M
20222022-12-31$102.7M$44.4M+76.08%
20212021-12-31$58.3M$730,000+1.27%
20202020-12-31$57.6M$82.8M
20192019-12-31−$25.2M

RedHill Biopharma net debt trends

Over the last five fiscal years, RedHill Biopharma's net debt decreased from $57.6M to −$2.9M, a change of −$60.5M. The latest reported quarter, Q4 2025, shows −$2.9M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review RedHill Biopharma source filings ↗

Community posts

It’s quiet here.

No posts about RDHL yet. Start the conversation.

Write the first post